Monogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults
Open Access
- 1 December 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 11 (6) , e200326
Abstract
A recent explosion in genomic testing has led to the identification of several genetic disorders that mimic CNS-specific autoimmune disorders. Such monogenic disorders, although rare, represent a diagnostic challenge because of their diverse phenotypes and overlapping features. Early recognition of these disorders is crucial not only to prevent overtreatment with immunotherapy but also to ensure that targeted treatments are available for many of these disorders. This review explores some of the monogenic disorders that can masquerade as neuroinflammatory phenotypes. These clinical vignettes are stratified according to neuroanatomical localization along the neuroaxis: supratentorial white matter, gray matter, brainstem, and spinal cord involvement. Through these cases, we discuss how clinical, laboratory, and neuroimaging red flags, such as early onset, relentless progression despite immunotherapy, and lack of CSF markers of inflammation, can guide specific diagnostic workup. In the next section, we highlight the approach to genetic testing in identifying monogenic mimickers. Finally, we discuss a selected list of currently available and emerging therapeutic strategies for some of these disorders. These include JAK inhibitors for Aicardi-Goutières syndrome, anti-TNF therapy for adenosine deaminase 2 deficiency (DADA2), and gene replacement therapy for X-linked adrenoleukodystrophy. By providing a comprehensive and systematic clinical approach, this review aims to equip neurologists with a framework to navigate diagnostic evaluations for such monogenic disorders.Keywords
This publication has 59 references indexed in Scilit:
- Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic NeuropathyJAMA Ophthalmology, 2025
- POLG-related mitochondrial disease mimicking autoimmune encephalitisJournal of Neurology, 2024
- Deficiency of adenosine deaminase 2 (DADA2): ReviewBest Practice & Research Clinical Rheumatology, 2023
- Treatment Strategies for Central Nervous System Effects in Primary and Secondary Haemophagocytic Lymphohistiocytosis in ChildrenCurrent Treatment Options in Neurology, 2022
- Novel NAXE variants as a cause for neurometabolic disorder: implications for treatmentJournal of Neurology, 2019
- Natural history of neurological abnormalities in cerebrotendinous xanthomatosisJournal of Inherited Metabolic Disease, 2018
- Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathiesAnnals of Neurology, 2018
- The Undiagnosed Diseases Network of the National Institutes of HealthJAMA, 2015
- Clinical whole exome sequencing in child neurology practiceAnnals of Neurology, 2014
- Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDH apheresisNeurological Sciences, 2004